Cargando…
On the Performance of Trimetazidine and Vitamin E as Pharmacoprotection Agents in Cyclosporin A-Induced Toxicity
The immunosuppressant drug cyclosporin A (CyA) has been used in diseases with immunological basis and in transplant patients. Nephrotoxicity and hepatotoxicity are the main adverse effects of this drug. To find a protective drug against those effects we assayed the cardioprotector Trimetazidine (TMZ...
Autores principales: | Cristina, De la Cruz Rodríguez Lilia, del Rosario, Rey María, Carmen Rosa, Araujo, Ana Veronica, Oldano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654278/ https://www.ncbi.nlm.nih.gov/pubmed/23691353 http://dx.doi.org/10.1155/2013/605640 |
Ejemplares similares
-
Trimetazidine in Heart Failure
por: Shu, Hongyang, et al.
Publicado: (2021) -
TRimetazidine as an Agent to affeCt clopidogrEl Response: The TRACER Study
por: Seecheran, Naveen, et al.
Publicado: (2019) -
Meta-analysis of trimetazidine treatment for cardiomyopathy
por: Fan, Qian, et al.
Publicado: (2018) -
Cardiac Effects of Trimetazidine in Diabetic Rats
por: Mansur, Alfredo J.
Publicado: (2019) -
The mitochondrial metabolic reprogramming agent trimetazidine as an ‘exercise mimetic’ in cachectic C26‐bearing mice
por: Molinari, Francesca, et al.
Publicado: (2017)